![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CASE REPORTS
Chirurgia 2015 October;28(5):205-7
Copyright © 2015 EDIZIONI MINERVA MEDICA
language: English
Heart transplantation in high risk arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) patient with cerebrovascular event
Demirozu Z. T. 1, Kucukaksu D. S. 2
1 Koc University Hospital, Istanbul, Turkey; 2 Department of Heart Transplant and Mechanical Circulatory Support, Sisli Florence Nightingale Hospital, Istanbul Bilim Medical Faculty, Istanbul, Turkey
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) usually originates from right ventricle, has a prevalence 1 in 1000 and leading cause of death in people aged less than 35 years of age, also desmosome mutations and family history can be seen in this disease. We reviewed the literature and reported the high risk patient with arrhythmogenic right ventricular dysplasia/ cardiomyopathy (ARVD/C) with right cerebral infarction. He had T wave inversion in chest leads V1 to V4 and had premature ventricular complexes of left bundle branch block and left axis deviation, or right bundle branch block (RBB) had implantable cardioverter defibrillator (ICD) implantation and fulfilled the task force criteria for diagnosis of ARVD/C. He had a history of cerebrovascular event, an ischemic stroke and had a family history of ARVD/C. He was in NYHA Class III-IV while he admitted to our clinic and was receiving maximum medical treatment. He was listed as Status IA due to biventriculer heart failure and had final therapeutic option as an orthotopic heart transplantation.